Migraine is a frequent, disabling condition, of great social and economical impact worldwide. This condition is more frequent in women and subjects with autoimmune and/or inflammatory diseases.
Official registry: https://clinicaltrials.gov/study/NCT07067112 · University Hospital, Clermont-Ferrand · enrollment listed as 24
This study does not use the classic phase 1–4 drug ladder. It may be a device, a behavior program, a surgery timing study, or an early feasibility test.
Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.
If you join, the listed intervention(s) are Blood sampling, questionnaire and phone call. The registry lists allocation as randomized. Migraine is a frequent, disabling condition, of great social and economical impact worldwide.
They plan to enroll about 24 people at Clermont-Ferrand. Taking part typically means an infusion or injection of a biologic plus check-ins.
Suppressive Functions of Regulatory T Cells in Migraine
Interventions: Blood sampling, questionnaire and phone call
Primary outcome (registry wording): Treg cell suppressive functions
Lise Laclautre
promo_interne_drci@chu-clermontferrand.fr
Published on ClinicalTrials.gov. Contact them as a possible participant. They decide eligibility.
This study wants to test the safety and how well it works of BHV-3000 versus dummy treatment (placebo) in the acute treatment of moderate or severe migraine in children and adolescents.
NCT04649242 · Official ClinicalTrials.gov record · Pfizer
This study wants to test the long-term safety of rimegepant in the acute treatment of migraine in children and adolescents (≥ 6 to \< 18 years of age).
NCT04743141 · Official ClinicalTrials.gov record · Pfizer
To find out if eptinezumab is better than dummy treatment (placebo) (normal saline solution) in lowering the number of days with migraine in young people ages 12 to 17 with chronic migraine.
NCT04965675 · Official ClinicalTrials.gov record · H. Lundbeck A/S
The sponsor posted status “Recruiting” on ClinicalTrials.gov at last ingest. Sites can pause independently. Confirm with the official record and the listed contact.
Not a traditional drug phase. Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.
No. The inclusion and exclusion lists on this page are readable extracts of the public eligibility block. Only the study team can screen you.
How to read a ClinicalTrials.gov record · Questions to ask the coordinator · Glossary